NCT
HOME CURRENT ARCHIVE COVID-19
HOME CURRENT ARCHIVE PUBLISH INSTRUCTIONS
FOR AUTHORS COVID-19 LOG IN / REGISTER HISTORY ABOUT US DIRECTORY CONTACT
Diagnosis and classification of COPD

Main indicators in order to consider COPD
Complementary studies in patients suffering from COPD
Following and monitoring of patients suffering from COPD
Multisystemic evaluation and diagnosis of COPD





2007, Suplement 2

2007; 66 (S2)






ABSTRACT

No abstract

KEYWORDS

.

REFERENCES

  1. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Document 2006. NHLB/WHO Global initiative for chronic lung Disease. www.goldcopd.org

  2. Segundo consenso mexicano para el diagnóstico y tratamiento de la EPOC. Revista del Instituto Nacional de Enfermedades Respiratorias y de la Sociedad Mexicana de Neumología y Cirugía de Tórax. Edición especial. 2003: 9-13.

  3. Fletcher CM, Peto, Tinker CM. The natural history of chronic bronchitis and emphysema. British Medical Journal 1977; 1: 1645-1648.

  4. Pandey MR. Domestic smoke pollution and chronic bronchitis in a rural community of the hill region of Nepal. Thorax 1984; 39: 337-339.

  5. Melchum L, García L, Sansores R, Pérez Padilla R. Factores de riesgo asociados a bronquitis crónica y enfermedad pulmonar obstructiva crónica en el Instituto Nacional de Enfermedades Respiratorias. Neumol Cir Tórax (Méx) 1989; 48:42.

  6. Sansores R, Pérez-Padilla JR, Selman M, Rubio-Monteverde H. Firewood smoke as a possible causal factor in chronic bronchitis. Rev Inst Nal Enf Resp 1990; 3: 125-127.

  7. Pérez Padilla, Regalado J, Sverre V, Paré P, Chapela R, et al. Exposure to biomass smoke and chronic airway disease in mexican woman. A case-control study. Am J Respir Crit Care Med 1996; 154: 701-706.

  8. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 581-586.

  9. American Thoracic Society. Lung function testing: Selection of reference values and interpretative strategies. Am rev Respir Dis 1991; 144: 1202-1218.

  10. Pérez Padilla JR. Valdivia G, Muiño A, López MV, Márquez MN, et al. Valores de referencia espirométrica en 5 grandes ciudades de Latinoamérica para sujetos de 40 o más años de edad. Arch Bronconeumol 2006; 42(7): 317-25.

  11. Pérez Padilla JR, Vázquez-García JC. Estimación de los valores gasométricos en diferentes alturas sobre el nivel del mar en México. Rev Inv Clin 2000; 52: 148-155.

  12. Parr DG, Dawkins PA, Stockley RA. Computed Tomography: a new gold standard for the clinical assessment of emphysema. Am J Respir Crit Care Med 2006; 15(174): 954-55.

  13. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 1005-1012.

  14. Agusti AGC. COPD. A multi-component disease: Implications for management. Respiratory Medicine 2005; 99: 670-682.

  15. Gross NJ. Extra-pulmonary effects of chronic obstructive pulmonary disease. Curr Opin Pulm Med 2001; 7: 84-92.

  16. Thomson NC, Chaudhuri R, Livingston E. Asthma and cigarette smoking. Eur Respir J 2004; 24: 822-833.

  17. Hnizdo E, Singh T, Churchyard G. Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment. Thorax 2000; 55: 32-38.


2007, Suplement 2

2007; 66 (S2)